Syros Pharmaceuticals
(NASDAQ:SYRS)
$5.51
0.03[0.55%]
At close: May 15
$5.51
0[0.00%]
After Hours: 4:03PM EDT
Q1 2024 Earnings were released on Tue May 14th, before the market open
The most recent conference call was at 8:30 AM, 5 days ago Click to view past webcast
OverviewNewsEarningsGuidanceDividendsAnalyst RatingsInsider TradesShort Interest

Syros Pharmaceuticals Stock (NASDAQ:SYRS), Quotes and News Summary

Syros Pharmaceuticals Stock (NASDAQ: SYRS) stock price, news, charts, stock research, profile.

Open$5.360
Close$5.450
Volume / Avg.163.176K / 197.042K
Day Range5.290 - 5.520
52 Wk Range2.090 - 8.170
Market Cap$147.273M
P/E Ratio-
Dividend Yield-
ExchangeNASDAQ
RSI
54
Short Interest
5.91%
Days to Cover10.21

Recent News

Crude Oil Down Over 1%; Cognyte Software Shares Plummet
U.S. stocks traded lower toward the end of trading, with the S&P 500 falling around 0.4% on Tuesday. The Dow traded down 0.46% to 38,713.72 while the NASDAQ fell 0.24% to 16,215.32. The S&P 500 also fell, dropping, 0.39% to 5,182.36.
Avi Kapoor
Why Tilray Brands Shares Are Trading Lower By Around 22%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Shares of Tilray Brands, Inc. (NASDAQ: TLRY) fell sharply during Tuesday’s session after the company missed third-quarter estimates and said it no longer expects to generate positive adjusted free
Avi Kapoor
Top 3 Health Care Stocks You'll Regret Missing This Month
The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies.
Avi Kapoor
-%

Financials

Quarterly
Annual
Name
Revenue
Change
Gross
Change
EBITDA
Change
EBIT
Change
Earnings
Change
Analyst Trend
2
Apr
1
May
Buy
Hold
Sell
Strong Sell
Analyst Rating
12345
4.3
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell

Compare

EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
SYRS
OTLK

FAQ

Q

How do I buy Syros Pharmaceuticals (SYRS) stock?

A

You can purchase shares of Syros Pharmaceuticals (NASDAQ: SYRS) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Syros Pharmaceuticals's (SYRS) competitors?

A

Other companies in Syros Pharmaceuticals’s space includes: Outlook Therapeutics (NASDAQ:OTLK), Renovaro (NASDAQ:RENB), CytomX Therapeutics (NASDAQ:CTMX), Adverum Biotechnologies (NASDAQ:ADVM) and Tevogen Bio Holdings (NASDAQ:TVGN).

Q

What is the target price for Syros Pharmaceuticals (SYRS) stock?

A

The latest price target for Syros Pharmaceuticals (NASDAQ: SYRS) was reported by HC Wainwright & Co. on Wednesday, May 15, 2024. The analyst firm set a price target for 15.00 expecting SYRS to rise to within 12 months (a possible 172.23% upside). 5 analyst firms have reported ratings in the last year.

Q

Current Stock Price for Syros Pharmaceuticals (SYRS)?

A

The stock price for Syros Pharmaceuticals (NASDAQ: SYRS) is $5.51 last updated May 15, 2024 at 4:03 PM EDT.

Q

Does Syros Pharmaceuticals (SYRS) pay a dividend?

A

There are no upcoming dividends for Syros Pharmaceuticals.

Q

When is Syros Pharmaceuticals (NASDAQ:SYRS) reporting earnings?

A

Syros Pharmaceuticals’s Q2 earnings are confirmed for Tuesday, August 6, 2024.

Q

Is Syros Pharmaceuticals (SYRS) going to split?

A

There is no upcoming split for Syros Pharmaceuticals.

Q

What sector and industry does Syros Pharmaceuticals (SYRS) operate in?

A

Syros Pharmaceuticals is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

People Also Watch